| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $13.6M | -15.7% | -27.7% |
| SG&A Expense | $6.0M | -6.6% | -3.8% |
| Operating Income | -$19.7M | +13.1% | +21.7% |
| Net Income | -$18.2M | +13.2% | +18.7% |
| EPS (Basic) | -$0.47 | +14.5% | +20.3% |
| EPS (Diluted) | -$0.47 | +14.5% | +20.3% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $35.4M | -15.5% | -18.4% |
| Short-term Investments | $93.8M | -1.8% | -34.8% |
| Current Assets | $130.4M | -5.8% | -31.0% |
| Total Assets | $145.3M | -8.4% | -32.3% |
| Current Liabilities | $14.9M | +10.9% | +0.5% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$48.4M | — | — |
| Capital Expenditures | $1.4M | — | — |
| Investing Cash Flow | $44.6M | — | — |
| Financing Cash Flow | -$557K | — | — |
| Free Cash Flow | -$49.9M | — | — |
| $16.7M |
| +7.4% |
| -6.2% |
| Stockholders' Equity | $128.6M | -10.1% | -34.7% |